NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31

NEUTRA CORP.

Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

NEUTRA CORP. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-01-31	FY 2022 2022-01-31	FY 2021 2021-01-31	FY 2020 2020-01-31	FY 2019 2019-01-31	FY 2018 2018-01-31	FY 2017 2017-01-31	FY 2016 2016-01-31	FY 2015 2015-01-31	FY 2014 2014-01-31	FY 2013 2013-01-31	FY 2012 2012-01-31	FY 2011 2011-01-31
Cash & Equivalents	0.00	0.00	0.02	0.18	0	0	0	0.00	0.01	0.05	0.01	0.03	0.01
Cash & Short-Term Investments	0.00	0.00	0.02	0.18	0	0	0	0.00	0.01	0.05	0.01	0.03	0.01
Receivables	–	–	0.00	–	–	–	–	–	–	–	–	–	–
Inventory	0.02	–	–	0.00	–	–	–	–	–	–	–	–	–
Total Current Assets	0.03	0.00	0.02	0.18	0.16	0.01	–	0.00	0.01	0.05	0.01	0.03	0.01
Property, Plant & Equipment	0.05	0.13	0.17	–	–	–	–	–	–	–	–	–	–
Gross Property, Plant & Equipment	0.24	0.24	0.20	–	–	–	–	–	–	–	–	–	–
Accumulated Depreciation	-0.19	-0.11	-0.03	–	–	–	–	–	–	–	–	–	–
Total Assets	0.08	0.13	0.19	0.18	0.16	0.01	0	0.00	0.01	0.05	0.01	0.03	0.01
Accounts Payable	0.23	0.13	0.43	0.41	0.46	0.46	0.47	0.39	0.33	0.24	0.08	0.02	0.00
Short-Term Debt	–	–	–	–	–	–	–	–	–	0.10	0.18	0.05	–
Current Debt	–	–	–	–	–	–	–	–	–	0.10	0.18	0.05	–
Other Current Liabilities	–	–	–	–	–	–	–	–	–	–	0.01	–	–
Total Current Liabilities	0.76	1.15	1.00	1.03	1.27	0.75	0.63	0.40	0.34	0.34	0.26	0.06	–
Long-Term Debt	0.05	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	0.81	1.15	1.00	1.03	1.27	0.78	0.68	0.43	0.39	0.55	0.27	0.06	0.00
Total Debt	0.05	–	–	–	–	–	–	–	–	0.10	0.18	0.05	–
Preferred Stock	–	–	–	–	0.00	0.00	0.00	0.00	–	–	–	–	–
Common Stock	2.74	1.78	1.49	0.62	0.03	0.01	0.00	0.00	0.00	0.00	–	–	–
Additional Paid-In Capital	7.89	7.82	7.43	8.09	7.72	5.66	5.24	4.62	3.16	1.20	0.18	0.05	0.01
Retained Earnings	-11	-11	-10	-9.56	-8.86	-6.43	-5.92	-5.05	-3.60	-1.71	-0.45	-0.08	0.00
Shareholders' Equity	-0.77	-1.27	-0.97	-0.85	-1.11	-0.76	-0.68	-0.43	-0.39	-0.50	-0.27	-0.03	0.01
Total Equity	-0.77	-1.27	-0.97	-0.85	-1.11	-0.76	-0.68	-0.43	-0.39	-0.50	-0.27	-0.03	0.01
Total Liabilities & Equity	0.08	0.13	0.19	0.18	0.16	0.01	0	0.00	0.01	0.05	0.01	0.03	0.01
Shares Outstanding(shares)	2,744	1,782	1,493	616	34	6.84	2.98	1.72	0.90	0.30	0.10	0.01	0.18

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Oct 31, 2023

Profitability, TTM

Gross margin: 46.2%
Operating margin: -1457.1%
Net margin: -2723.6%
Return on equity, FY2023: 54.9%

Financial strength

Current ratio: 0.02
Debt to equity: -0.06
Debt to assets: 201.0%
Cash to current liabilities: 0.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –